SARS-CoV-2 Antibody Positivity and Prevalence in an Outpatient Medical Setting in Las Vegas, NV

Sassan Kaveh; Kimball Kaufman; Tina Danai; Hossein Akhondi

SARS-CoV-2 Antibody Positivity and Prevalence in an Outpatient Medical Setting in Las Vegas, NV

Sassan Kaveh
, Kimball Kaufman
, Tina Danai
, Hossein Akhondi

Frontline Medical Group
MountainView Hospital-Nevada
University of Nevada, Las Vegas

Research output: Contribution to journal › Article › peer-review

Abstract

Background: SARS-CoV-2 antibody testing shows the prevalence of COVID-19 disease in different communities and has epidemiological significance.

Methods: SARS-CoV-2 IgM and IgG were tested in 319 patients, staff and visitors of a primary care clinic in Las Vegas, NV on a continuous as-requested basis.

Results: Prevalence of SARS-CoV-2 antibodies was 3.76% in a primary care office in Las Vegas, NV. Positivity of IgM was 0.31% and IgG 3.44%. The most common symptoms reported amongst those who tested positive were cough, shortness of breath and loss of smell and taste. The most common comorbidities included hypertension, chronic lung disease, seasonal allergies, and type 2 diabetes mellitus, in that order.

Conclusion: Prevalence was 2.3% in Washoe County, NV in June 2020 and 3.76% in Clark County, NV in April–June 2020. This has important implications for heavily populated urban areas.

Original language	American English
Journal	HCA Healthcare Journal of Medicine
State	Published - 1800
Externally published	Yes

Keywords

SARS-CoV-2
COVID-19
prevalence
antibody testing
SARS-CoV-2 IgG
SARS-CoV-2 IgM
seroepidemiologic studies
viral antibodies
coronavirus infections
pandemics
serologic tests

Disciplines

Respiratory Tract Diseases
Virus Diseases

Access to Document

SARS-CoV-2 prevalence in Las VegasFinal published version, 86.5 KBLicense: Unspecified

Cite this

@article{3580b2614a5045d4acae952f0accf3fb,

title = "SARS-CoV-2 Antibody Positivity and Prevalence in an Outpatient Medical Setting in Las Vegas, NV",

abstract = " Background: SARS-CoV-2 antibody testing shows the prevalence of COVID-19 disease in different communities and has epidemiological significance. Methods: SARS-CoV-2 IgM and IgG were tested in 319 patients, staff and visitors of a primary care clinic in Las Vegas, NV on a continuous as-requested basis. Results: Prevalence of SARS-CoV-2 antibodies was 3.76\% in a primary care office in Las Vegas, NV. Positivity of IgM was 0.31\% and IgG 3.44\%. The most common symptoms reported amongst those who tested positive were cough, shortness of breath and loss of smell and taste. The most common comorbidities included hypertension, chronic lung disease, seasonal allergies, and type 2 diabetes mellitus, in that order. Conclusion: Prevalence was 2.3\% in Washoe County, NV in June 2020 and 3.76\% in Clark County, NV in April–June 2020. This has important implications for heavily populated urban areas.",

keywords = "SARS-CoV-2, COVID-19, prevalence, antibody testing, SARS-CoV-2 IgG, SARS-CoV-2 IgM, seroepidemiologic studies, viral antibodies, coronavirus infections, pandemics, serologic tests",

author = "Sassan Kaveh and Kimball Kaufman and Tina Danai and Hossein Akhondi",

year = "1800",

language = "American English",

journal = "HCA Healthcare Journal of Medicine",

issn = "2689-0216",

}

TY - JOUR

T1 - SARS-CoV-2 Antibody Positivity and Prevalence in an Outpatient Medical Setting in Las Vegas, NV

AU - Kaveh, Sassan

AU - Kaufman, Kimball

AU - Danai, Tina

AU - Akhondi, Hossein

PY - 1800

Y1 - 1800

N2 - Background: SARS-CoV-2 antibody testing shows the prevalence of COVID-19 disease in different communities and has epidemiological significance. Methods: SARS-CoV-2 IgM and IgG were tested in 319 patients, staff and visitors of a primary care clinic in Las Vegas, NV on a continuous as-requested basis. Results: Prevalence of SARS-CoV-2 antibodies was 3.76% in a primary care office in Las Vegas, NV. Positivity of IgM was 0.31% and IgG 3.44%. The most common symptoms reported amongst those who tested positive were cough, shortness of breath and loss of smell and taste. The most common comorbidities included hypertension, chronic lung disease, seasonal allergies, and type 2 diabetes mellitus, in that order. Conclusion: Prevalence was 2.3% in Washoe County, NV in June 2020 and 3.76% in Clark County, NV in April–June 2020. This has important implications for heavily populated urban areas.

AB - Background: SARS-CoV-2 antibody testing shows the prevalence of COVID-19 disease in different communities and has epidemiological significance. Methods: SARS-CoV-2 IgM and IgG were tested in 319 patients, staff and visitors of a primary care clinic in Las Vegas, NV on a continuous as-requested basis. Results: Prevalence of SARS-CoV-2 antibodies was 3.76% in a primary care office in Las Vegas, NV. Positivity of IgM was 0.31% and IgG 3.44%. The most common symptoms reported amongst those who tested positive were cough, shortness of breath and loss of smell and taste. The most common comorbidities included hypertension, chronic lung disease, seasonal allergies, and type 2 diabetes mellitus, in that order. Conclusion: Prevalence was 2.3% in Washoe County, NV in June 2020 and 3.76% in Clark County, NV in April–June 2020. This has important implications for heavily populated urban areas.

KW - SARS-CoV-2

KW - COVID-19

KW - prevalence

KW - antibody testing

KW - SARS-CoV-2 IgG

KW - SARS-CoV-2 IgM

KW - seroepidemiologic studies

KW - viral antibodies

KW - coronavirus infections

KW - pandemics

KW - serologic tests

UR - https://scholarlycommons.hcahealthcare.com/hcahealthcarejournal/vol1/iss0/18

M3 - Article

SN - 2689-0216

JO - HCA Healthcare Journal of Medicine

JF - HCA Healthcare Journal of Medicine

ER -

SARS-CoV-2 Antibody Positivity and Prevalence in an Outpatient Medical Setting in Las Vegas, NV

Abstract

Keywords

Disciplines

Access to Document

Other files and links

Cite this